|View printer-friendly version|
Businesses Can Order Pixel by Labcorp® COVID-19 PCR Test Home Collection Kits Online or Through Labcorp Employer Services
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210420006151/en/
Photo courtesy of
The small business offering enables bulk purchasing, and is well-suited for restaurants, professional services offices, event planners and small venue owners. Bulk purchasing saves on shipping costs, and those savings are passed on to the small business. Kits can be purchased in multiples of six, with a maximum of 120 kits per order, at Pixel by
“By making it easier for employees to get tested, we are supporting communities and small businesses across the country,” said
The offering for small businesses is yet another example of the company’s commitment to expanding access to testing so people can safely return to work and everyday activities. As states continue to reopen, small businesses will need a convenient way to ensure the safety of their employees and patrons. Many of these businesses are not able to offer remote working environments for their employees. The small business offering through Pixel by
Upon receiving a Pixel by Labcorp COVID-19 PCR Test Home Collection Kit from their employer or an event organizer, individuals self-administer the test using a short nasal swab and send their sample back to
If a COVID-19 test is positive, a
Labcorp’s COVID-19 PCR test has not been FDA cleared or approved and has been authorized by the FDA under an emergency use authorization only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens. The test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostic tests for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.
Cautionary Statement Regarding Forward-Looking Statements
This press release contains forward-looking statements, including but not limited to statements with respect to clinical laboratory testing and the potential benefits of a COVID-19 test home collection kit and our responses to and the expected future impacts of the COVID-19 pandemic and the opportunities for future growth.
Each of the forward-looking statements is subject to change based on various important factors, many of which are beyond the company’s control, including without limitation, the impact of the COVID-19 pandemic and its impact on our business and financial condition and on general economic, business, and market conditions, our ability (or inability) to execute on our plans to respond to the COVID-19 pandemic, competitive actions and other unforeseen changes and general uncertainties in the marketplace, changes in government regulations, including healthcare reform, customer purchasing decisions, including changes in payer regulations or policies, other adverse actions of governmental and third-party payers, changes in testing guidelines or recommendations, federal, state, and local government responses to the COVID-19 pandemic, the effect of public opinion on the company’s reputation, adverse results in material litigation matters, the impact of changes in tax laws and regulations, failure to maintain or develop customer relationships, our ability to develop or acquire new products and adapt to technological changes, failure in information technology, systems or data security, adverse weather conditions, the number of revenue days in a financial period, employee relations, personnel costs, and the effect of exchange rate fluctuations. These factors, in some cases, have affected and in the future (together with other factors) could affect the company’s ability to implement the company’s business strategy and actual results could differ materially from those suggested by these forward-looking statements. As a result, readers are cautioned not to place undue reliance on any of our forward-looking statements.
The company has no obligation to provide any updates to these forward-looking statements even if its expectations change. All forward-looking statements are expressly qualified in their entirety by this cautionary statement. Further information on potential factors, risks and uncertainties that could affect operating and financial results is included in the company’s most recent Annual Report on Form 10-K and subsequent Forms 10-Q, including in each case under the heading RISK FACTORS, and in the company’s other filings with the
# # #